IL-6-induced stimulation of c-myc translation in multiple myeloma cells is mediated by myc internal ribosome entry site function and the RNA-binding protein, hnRNP A1.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Cancer Research

• Publication date

  2008-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-08-1066PMID 19074889PMCID PMC2701383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies.

  2008cited by this paper
• Heterogeneous Nuclear Ribonucleoprotein A1 Regulates Cyclin D1 and c-myc Internal Ribosome Entry Site Function through Akt Signaling*

  2008cited by this paper
• Subcellular relocalization of a trans-acting factor regulates XIAP IRES-dependent translation.

  2007cited by this paper
• AKT activity regulates the ability of mTOR inhibitors to prevent angiogenesis and VEGF expression in multiple myeloma cells

  2007cited by this paper
• Searching for IRES.

  2006cited by this paper
• Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling

  2006cited by this paper
• Targeting aurora kinases as therapy in multiple myeloma.

  2006cited by this paper
• The Mnks are novel components in the control of TNF alpha biosynthesis and phosphorylate and regulate hnRNP A1.

  2005cited by this paper
• Cyclin D1 and c-myc Internal Ribosome Entry Site (IRES)-dependent Translation Is Regulated by AKT Activity and Enhanced by Rapamycin through a p38 MAPK- and ERK-dependent Pathway*

  2005influential reference
• Regulation of heterogenous nuclear ribonucleoprotein A1 transport by phosphorylation in cells stressed by osmotic shock.

  2005cited by this paper
• Heterogeneous Nuclear Ribonucleoprotein A1 Is a Novel Internal Ribosome Entry Site trans-Acting Factor That Modulates Alternative Initiation of Translation of the Fibroblast Growth Factor 2 mRNA*

  2005cited by this paper
• AKT Activity Determines Sensitivity to Mammalian Target of Rapamycin (mTOR) Inhibitors by Regulating Cyclin D1 and c-myc Expression*

  2004cited by this paper
• The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation

  2004cited by this paper
• Cellular internal ribosome entry segments: structures, trans-acting factors and regulation of gene expression

  2004cited by this paper
• Downstream effectors of oncogenic ras in multiple myeloma cells.

  2003cited by this paper
• Signal Pathways Involved in Activation of p70S6K and Phosphorylation of 4E-BP1 following Exposure of Multiple Myeloma Tumor Cells to Interleukin-6*

  2002cited by this paper
• Ribonomics: identifying mRNA subsets in mRNP complexes using antibodies to RNA-binding proteins and genomic arrays.

  2002cited by this paper
• Chromosome translocations in multiple myeloma

  2001cited by this paper
• Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors.

  2001cited by this paper
• Mouse plasmacytoma: an experimental model of human multiple myeloma.

  2001cited by this paper
• Internal ribosome entry sites in eukaryotic mRNA molecules.

  2001cited by this paper
• The Mkk3/6-p38–Signaling Cascade Alters the Subcellular Distribution of Hnrnp A1 and Modulates Alternative Splicing Regulation

  2000cited by this paper
• Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors

  2000cited by this paper
• A mutation in the c-myc-IRES leads to enhanced internal ribosome entry in multiple myeloma: A novel mechanism of oncogene de-regulation

  2000cited by this paper
• Messenger RNA translation state: the second dimension of high-throughput expression screening.

  1999cited by this paper
• Interleukin-6-induced inhibition of multiple myeloma cell apoptosis: support for the hypothesis that protection is mediated via inhibition of the JNK/SAPK pathway.

  1998cited by this paper
• Mitogen‐activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2

  1997influential reference
• Transportin-mediated Nuclear Import of Heterogeneous Nuclear RNP Proteins

  1997cited by this paper
• Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III Trial.

  1996cited by this paper
• Aberrant translational control of the c-myc gene in multiple myeloma.

  1996cited by this paper
• Introduction of an activated N-ras oncogene alters the growth characteristics of the interleukin 6-dependent myeloma cell line ANBL6.

  1995cited by this paper
• Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma.

  1995cited by this paper
• Molecular biology of lymphomas.

  1993cited by this paper
• Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells

  1993cited by this paper
• Use of the two-hybrid system to identify the domain of p53 involved in oligomerization.

  1993cited by this paper
• myc function and regulation.

  1992cited by this paper
• Cancer : Principles and Practice of Oncology

  1982cited by this paper
• A Nuclear Export Signal in Hnrnp Al: a Signal-mediated, Temperature-dependent Nuclear Protein Export Pathway

  year unknowncited by this paper

• When Autoimmunity Meets Malignancy: A Rare Case of Concomitant Systemic Lupus and Multiple Myeloma

  2026cites this paper
• A novel polypeptide encoded by circSPIRE1 promotes prostate cancer proliferation and migration by restraining the ubiquitin-dependent degradation of LRP5

  2025cites this paper
• Enhanced identification of small molecules binding to hnRNPA1 via cryptic pockets mapping coupled with X-ray fragment screening

  2025cites this paper
• HnRNPAB promotes pancreatic ductal adenocarcinoma extravasation and liver metastasis by stablizing MYC mRNA.

  2024cites this paper
• Enhanced identification of small molecules binding to hnRNPA1 via cryptic pockets mapping coupled with X-Ray fragment screening

  2024cites this paper
• Emerging roles for heterogeneous ribonuclear proteins in normal and malignant B cells.

  2023cites this paper
• A comprehensive understanding of hnRNP A1 role in cancer: new perspectives on binding with noncoding RNA

  2022cites this paper
• RBMX suppresses tumorigenicity and progression of bladder cancer by interacting with the hnRNP A1 protein to regulate PKM alternative splicing

  2021cites this paper
• Annexin A2 binds the internal ribosomal entry site of c-myc mRNA and regulates its translation

  2021cites this paper
• Tetracaine hydrochloride induces cell cycle arrest in melanoma by downregulating hnRNPA1.

  2021cites this paper
• C1orf35 contributes to tumorigenesis by activating c-MYC transcription in multiple myeloma

  2020cites this paper
• Autocrine IL-6/STAT3 signaling aids development of acquired drug resistance in Group 3 medulloblastoma

  2020cites this paper
• Crosstalk Between MYC and lncRNAs in Hematological Malignancies

  2020influential citation
• IRES Trans-Acting Factors, Key Actors of the Stress Response

  2019cites this paper
• Heterogeneous nuclear ribonucleoprotein A1 promotes the expression of autophagy-related protein 6 in human colorectal cancer.

  2019cites this paper
• Computer-Aided Discovery of Small Molecules Targeting the RNA Splicing Activity of hnRNP A1 in Castration-Resistant Prostate Cancer

  2019cites this paper
• Fusobacterium nucleatum promotes M2 polarization of macrophages in the microenvironment of colorectal tumours via a TLR4-dependent mechanism

  2018cites this paper
• Translation acrobatics: how cancer cells exploit alternate modes of translational initiation

  2018cites this paper
• d-/l-Isothymidine incorporation in the core sequence of aptamer BC15 enhanced its binding affinity to the hnRNP A1 protein.

  2018cites this paper
• Tumor-related interleukins: old validated targets for new anti-cancer drug development

  2017cites this paper
• Emerging roles of hnRNPA1 in modulating malignant transformation

  2017cites this paper
• Methylarginines within the RGG-Motif Region of hnRNP A1 Affect Its IRES Trans-Acting Factor Activity and Are Required for hnRNP A1 Stress Granule Localization and Formation.

  2017cites this paper
• Nouveaux marqueurs dans la progression du cancer colorectal

  2017cites this paper
• hnRNP A1-mediated translational regulation of the G quadruplex-containing RON receptor tyrosine kinase mRNA linked to tumor progression

  2016cites this paper
• Differentiation Inducing Factor-1 Represses c-Myc and VEGF Expression in Myeloma Cells

  2016cites this paper
• Chronic inflammation contributes to the development of hepatocellular carcinoma by decreasing miR-122 levels

  2016cites this paper
• Oral squamous cancer cell exploits hnRNP A1 to regulate cell cycle and proliferation

  2015cites this paper
• Cap-Independent Translation in Hematological Malignancies

  2015cites this paper
• Bortezomib inhibits Burkitt's lymphoma cell proliferation by downregulating sumoylated hnRNP K and c-Myc expression

  2015cites this paper
• Therapeutic potential of targeting IRES-dependent c-myc translation in multiple myeloma cells during ER stress

  2015cites this paper
• Diverse Mechanisms of Translation Regulation and Their Role in Cancer

  2014cites this paper
• The Long Non-Coding RNA GAS5 Cooperates with the Eukaryotic Translation Initiation Factor 4E to Regulate c-Myc Translation

  2014cites this paper
• MNK1-Induced eIF-4E Phosphorylation in Myeloma Cells: A Pathway Mediating IL-6-Induced Expansion and Expression of Genes Involved in Metabolic and Proteotoxic Responses

  2014cites this paper
• Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer

  2014cites this paper
• Nucleolin enhances internal ribosomal entry site (IRES)-mediated translation of Sp1 in tumorigenesis.

  2014cites this paper
• Translation and Apoptosis in Cancer

  2014cites this paper
• The immune system in the pathogenesis of ovarian cancer.

  2013cites this paper
• The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients

  2013cites this paper
• Genetic and Molecular Epidemiology of Multiple Myeloma

  2013cites this paper
• Aiming to immune elimination of ovarian cancer stem cells.

  2013cites this paper
• IRES-Dependent, Cap-Independent Translation in Multiple Myeloma

  2013cites this paper
• Charakterisierung von Interleukin-16 als therapeutische Zielstruktur im Multiplen Myelom

  2013cites this paper
• MNK kinases facilitate c-myc IRES activity in rapamycin-treated multiple myeloma cells

  2013cites this paper
• Diversity in Genetic In Vivo Methods for Protein-Protein Interaction Studies: from the Yeast Two-Hybrid System to the Mammalian Split-Luciferase System

  2012cites this paper
• Proteomic analysis identifies differentially expressed proteins in AML1/ETO acute myeloid leukemia cells treated with DNMT inhibitors azacitidine and decitabine.

  2012cites this paper
• Versatility of RNA-Binding Proteins in Cancer

  2012cites this paper
• Poly(ADP-ribose) controls DE-cadherin-dependent stem cell maintenance and oocyte localization

  2012cites this paper
• IL-6 upregulation contributes to the reduction of miR-26a expression in hepatocellular carcinoma cells

  2012cites this paper
• Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma

  2012cites this paper
• Fifteen years of the yeast three-hybrid system: RNA-protein interactions under investigation.

  2012cites this paper
• IRES-dependent translation of egr2 is induced under inflammatory conditions.

  2012cites this paper
• Aptamer BC15 Against Heterogeneous Nuclear Ribonucleoprotein A1 Has Potential Value in Diagnosis and Therapy of Hepatocarcinoma

  2012cites this paper
• Interleukin-6 signaling pathway in targeted therapy for cancer.

  2012cites this paper
• Cellular IRES-mediated translation

  2011cites this paper
• Investigation of the intrinsic mechanism of drug resistance in multiple myeloma

  2011cites this paper
• Bortezomib and Osteoclasts and Osteoblasts

  2011cites this paper
• Signalling Towards IRES

  2011cites this paper
• The expression profile of RNA-binding proteins in primary and metastatic colorectal cancer: relationship of heterogeneous nuclear ribonucleoproteins with prognosis.

  2011cites this paper
• Clinical and Biological Implications of MYC Activation: A common difference between MGUS and newly diagnosed multiple myeloma

  2011cites this paper
• PP2A-B56α Controls Oncogene-Induced Senescence in Normal and Tumor Human Melanocytic Cells

  2011cites this paper
• Translational control in cancer

  2010cites this paper
• Northwestern profiling of potential translation-regulatory proteins in human breast epithelial cells and malignant breast tissues: evidence for pathological activation of the IGF1R IRES.

  2010cites this paper
• Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1

  2010influential citation
• Pathological Variations in 3′-untranslated Regions of Human Genes

  2010cites this paper
• IL-6-induced Enhancement of c-Myc Translation in Multiple Myeloma Cells

  2010cites this paper
• The regulation of protein synthesis in cancer.

  2009cites this paper